BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9143395)

  • 1. Successful treatment of orbital rhabdomyosarcoma in two infants using chemotherapy alone.
    Lackner H; Urban C
    Med Pediatr Oncol; 1997 Jun; 28(6):463-4. PubMed ID: 9143395
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of alveolar rhabdomyosarcoma of the orbit.
    Seregard S
    Acta Ophthalmol Scand; 2002 Dec; 80(6):660-4. PubMed ID: 12485290
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of rhabdomyosarcoma and other malignant mesenchymal tumours of childhood with ifosfamide + vincristine + dactinomycin (IVA) as front-line therapy (a SIOP study).
    Otten J; Flamant F; Rodary C; Brunat-Mentigny M; Dutou L; Olive D; Quintana E; Voûte PA
    Cancer Chemother Pharmacol; 1989; 24 Suppl 1():S30. PubMed ID: 2667788
    [No Abstract]   [Full Text] [Related]  

  • 4. Orbital rhabdomyosarcoma: improved survival with combined pulsed chemotherapy and irradiation.
    Ghafoor SY; Dudgeon J
    Br J Ophthalmol; 1985 Aug; 69(8):557-61. PubMed ID: 3839411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ifosfamide-induced renal tubular defect.
    Torres Valdivieso MJ; López Pérez J; Melero C; Vivanco JL; Muley R; Vara J
    Med Pediatr Oncol; 1994; 22(2):144-6. PubMed ID: 7505048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irreversible encephalopathy with ifosfamide/mesna.
    Salloum E; Flamant F; Ghosn M; Taleb N; Akatchereian C
    J Clin Oncol; 1987 Aug; 5(8):1303-4. PubMed ID: 3114437
    [No Abstract]   [Full Text] [Related]  

  • 7. Medical therapy of orbit rhabdomyosarcoma in children.
    Acquaviva A; Barberi L; Bernardini C; D'Ambrosio A; Lasorella G
    J Neurosurg Sci; 1982; 26(1):45-8. PubMed ID: 7143084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary chemotherapy in rhabdomyosarcomas and other malignant mesenchymal tumors of the orbit: results of the International Society of Pediatric Oncology MMT 84 Study.
    Rousseau P; Flamant F; Quintana E; Voute PA; Gentet JC
    J Clin Oncol; 1994 Mar; 12(3):516-21. PubMed ID: 7509854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
    Gupta AA; Anderson JR; Pappo AS; Spunt SL; Dasgupta R; Indelicato DJ; Hawkins DS
    Cancer; 2012 Feb; 118(4):1130-7. PubMed ID: 21761400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An unresolved issue in rhabdomyosarcoma treatment: The duration of chemotherapy.
    Bisogno G; Hawkins DS
    Pediatr Blood Cancer; 2020 May; 67(5):e28174. PubMed ID: 31994316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rhabdomyosarcoma of the corpus of the uterus: a case report.
    Scheidt P; Moerman PH; Vergote I
    Eur J Gynaecol Oncol; 2000; 21(4):371-3. PubMed ID: 11055485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive value of initial cytostatic response in primary unresectable rhabdomyosarcoma in children.
    Treuner J; Suder J; Keim M; Kaatsch P; Niethammer D
    Acta Oncol; 1989; 28(1):67-72. PubMed ID: 2706134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide.
    Arndt CA; Nascimento AG; Schroeder G; Schomberg PJ; Neglia JP; Sencer SF; Silberman TL; Moertel CL; Tillisch JK; Miser JS
    Eur J Cancer; 1998 Jul; 34(8):1224-9. PubMed ID: 9849484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VIVA (vinorelbine, ifosfamide, vincristine, actinomycin-D): A new regimen in the armamentarium of systemic therapy for high-risk rhabdomyosarcoma.
    Ferrari A; Chiaravalli S; Zecca M; Recupero S; Pascale S; Bergamaschi L; Casanova M
    Pediatr Blood Cancer; 2020 Nov; 67(11):e28649. PubMed ID: 32893953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary leukemia in a child conceived using in vitro fertilization.
    Kim YD; Kim KJ; Lee YH
    Pediatr Int; 2008 Dec; 50(6):831-2. PubMed ID: 19067904
    [No Abstract]   [Full Text] [Related]  

  • 16. Effectiveness of chemotherapy in rhabdomyosarcoma: example of orbital primary.
    Orbach D; Brisse H; Helfre S; Freneaux P; Husseini K; Aerts I; Desjardins L; Fattet S
    Expert Opin Pharmacother; 2003 Dec; 4(12):2165-74. PubMed ID: 14640915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhabdomyosarcoma of the orbit in a four months old infant in Zimbabwe: A case report.
    Chitsike I; Masanganise R; Sibanda D; Kuona P
    Cent Afr J Med; 2012; 58(5-6):26-9. PubMed ID: 26255332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modern treatment of vaginal embryonal rhabdomyosarcoma.
    Friedman M; Peretz BA; Nissenbaum M; Paldi E
    Obstet Gynecol Surv; 1986 Oct; 41(10):614-8. PubMed ID: 3534662
    [No Abstract]   [Full Text] [Related]  

  • 19. [Orbital rhabdomyosarcoma: difficulties with European treatment protocol].
    Olivier Pascual N; Calvo JM; Abelairas Gómez JM
    Arch Soc Esp Oftalmol; 2005 Jun; 80(6):331-8. PubMed ID: 15986273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rhabdomyosarcoma of extrahepatic biliary tree: initial treatment with chemotherapy and conservative surgery.
    Pollono DG; Tomarchio S; Berghoff R; Drut R; Urrutia A; Cédola J
    Med Pediatr Oncol; 1998 May; 30(5):290-3. PubMed ID: 9544225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.